Ameritas Investment Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History

Ameritas Investment Partners’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$978K	Hold	3,332	–	–	0.03%	650
2026 Q1	$929K	Hold	3,332	–	–	0.03%	632
2025 Q4	$1.01M	Sell	3,332 -90	-3%	-$28.1K	0.03%	607
2025 Q3	$959K	Sell	3,422 -189	-5%	-$51.4K	0.03%	625
2025 Q2	$871K	Sell	3,611 -181	-5%	-$42.8K	0.03%	654
2025 Q1	$924K	Sell	3,792 -65	-2%	-$19.6K	0.03%	630
2024 Q4	$1.27M	Sell	3,857 -71	-2%	-$24.1K	0.04%	534
2024 Q3	$1.31M	Buy	3,928 +3,687	+1,530%	+$1.17M	0.04%	530
2024 Q2	$65.8K	Hold	241	–	–	﹤0.01%	1984
2024 Q1	$83.4K	Hold	241	–	–	﹤0.01%	1855
2023 Q4	$77.8K	Hold	241	–	–	﹤0.01%	1903
2023 Q3	$86.4K	Sell	241 -48	-17%	-$18.5K	﹤0.01%	1757
2023 Q2	$110K	Hold	289	–	–	﹤0.01%	1534
2023 Q1	$138K	Hold	289	–	–	0.01%	1309
2022 Q4	$135K	Hold	289	–	–	0.01%	1379
2022 Q3	$120K	Hold	289	–	–	0.01%	1367
2022 Q2	$143K	Hold	289	–	–	0.01%	1261
2022 Q1	$163K	Hold	289	–	–	0.01%	1306
2021 Q4	$218K	Hold	289	–	–	0.01%	1173
2021 Q3	$216K	Sell	289 -24	-8%	-$18K	0.01%	1149
2021 Q2	$202K	Hold	313	–	–	0.01%	1242
2021 Q1	$179K	Hold	313	–	–	0.01%	1291
2020 Q4	$182K	Sell	313 -31	-9%	-$17.7K	0.01%	1206
2020 Q3	$177K	Hold	344	–	–	0.01%	1102
2020 Q2	$155K	Sell	344 -5,733	-94%	-$2.53M	0.01%	1140
2020 Q1	$2.13M	Hold	6,077	–	–	0.12%	157
2019 Q4	$2.25M	Hold	6,077	–	–	0.1%	207
2019 Q3	$2.02M	Buy	6,077 +249	+4%	+$81.2K	0.09%	225
2019 Q2	$1.82M	Sell	5,828 -92	-2%	-$27.5K	0.08%	266
2019 Q1	$1.81M	Hold	5,920	–	–	0.08%	266
2018 Q4	$1.38M	Hold	5,920	–	–	0.08%	312
2018 Q3	$1.85M	Sell	5,920 -107	-2%	-$33.2K	0.09%	279
2018 Q2	$1.74M	Hold	6,027	–	–	0.08%	286
2018 Q1	$1.51M	Hold	6,027	–	–	0.07%	351
2017 Q4	$1.44M	Sell	6,027 -202	-3%	-$48.9K	0.07%	390
2017 Q3	$1.36M	Hold	6,229	–	–	0.06%	391
2017 Q2	$1.41M	Buy	6,229 +100	+2%	+$21.8K	0.07%	372
2017 Q1	$1.22M	Sell	6,129 -96	-2%	-$18.5K	0.06%	426
2016 Q4	$1.14M	Hold	6,225	–	–	0.06%	455
2016 Q3	$1.02M	Buy	6,225 +2,925	+89%	+$444K	0.06%	471
2016 Q2	$472K	Buy	3,300 +162	+5%	+$23.1K	0.03%	629
2016 Q1	$429K	Hold	3,138	–	–	0.03%	654
2015 Q4	$435K	Buy	3,138 +73	+2%	+$10.1K	0.03%	627
2015 Q3	$412K	Hold	3,065	–	–	0.03%	632
2015 Q2	$462K	Hold	3,065	–	–	0.03%	625
2015 Q1	$414K	Hold	3,065	–	–	0.03%	687
2014 Q4	$370K	Hold	3,065	–	–	0.03%	738
2014 Q3	$348K	Hold	3,065	–	–	0.02%	734
2014 Q2	$367K	Hold	3,065	–	–	0.03%	745
2014 Q1	$393K	Sell	3,065 -81	-3%	-$10.4K	0.03%	679
2013 Q4	$389K	Hold	3,146	–	–	0.03%	695
2013 Q3	$370K	Buy	+3,146	New	+$371K	0.03%	651

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Ameritas Investment Partners's BIO Position: Q2 2026 in Review

Ameritas Investment Partners held its Bio-Rad Laboratories Class A (BIO) position steady in Q2 2026 at 3,332 shares worth $978K. The position accounts for 0.03% of the portfolio, ranked #650.

Ameritas Investment Partners first reported a position in BIO in Q3 2013 and has held it in 52 quarters since. The position peaked at $2.25M in Q4 2019. 400 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

Ameritas Investment Partners held 3,332 shares of Bio-Rad Laboratories Class A worth $978K as of Q2 2026.
Ameritas Investment Partners left its Bio-Rad Laboratories Class A share count unchanged in Q2 2026.
Bio-Rad Laboratories Class A made up 0.03% of Ameritas Investment Partners's portfolio in Q2 2026, its #650 holding.
Ameritas Investment Partners first reported a position in Bio-Rad Laboratories Class A in Q3 2013 and has held it in 52 quarters since.
Ameritas Investment Partners's Bio-Rad Laboratories Class A position peaked at $2.25M in Q4 2019.
400 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.